A detailed history of Palo Alto Investors LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 140,681 shares of ALNY stock, worth $34.2 Million. This represents 5.32% of its overall portfolio holdings.

Number of Shares
140,681
Holding current value
$34.2 Million
% of portfolio
5.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$233.81 - $287.01 $32.9 Million - $40.4 Million
140,681 New
140,681 $38.7 Million
Q1 2024

May 15, 2024

BUY
$146.51 - $198.2 $4.15 Million - $5.61 Million
28,329 Added 18.34%
182,766 $27.3 Million
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $23.4 Million - $30.4 Million
154,437 New
154,437 $29.6 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.